Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions ...Middle East

PR Newswire - News
Lilly announces details of presentations at American Diabetes Associations (ADA) 85th Scientific Sessions

INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the American Diabetes...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions )

    Also on site :



    Latest News